CHRISTINA YEAST: Open Payments
NPI 1851952345 · SAINT LOUIS, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,986 in 122 payments from 20 companies in 2025. Trend: 2023 $1,720 · 2024 $523 · 2025 $1,986
Food & beverage: $1,986
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 17 | $272 |
| GlaxoSmithKline, LLC. | 15 | $250 |
| ABBVIE INC. | 14 | $240 |
| Novo Nordisk Inc | 12 | $229 |
| Otsuka America Pharmaceutical, Inc. | 16 | $189 |
| PFIZER INC. | 15 | $188 |
| Amgen Inc. | 7 | $133 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $109 |
| Exact Sciences Corporation | 4 | $93 |
| Viatris Specialty LLC | 2 | $46 |
Products named: TRELEGY ELLIPTA, REXULTI, MOUNJARO, NURTEC ODT, JARDIANCE, UBRELVY, Rybelsus, OTEZLA.
Industry payments across MO — which companies pay providers there.
